Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
Status:
Completed
Trial end date:
2017-07-28
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if adding the combination of abiraterone
acetate and prednisone with or without enzalutamide to hormonal therapy can help to control
prostate cancer when given before surgery. The safety of the drug combination will also be
studied.